Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.000
+0.004 (0.40%)
Nov 2, 2026, 5:29 PM CET
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 154.98 million as of November 2, 2026. It is the 38,499th most valuable company in the world and the 547th biggest in Sweden. Its market cap has decreased by 88.93% in one year.
Market Cap
154.98M
Enterprise Value
-150.44M
Revenue
477.00K
Global Rank
Country Rank
#547 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 154.98M, an increase of 16.96%. That is a compound annual growth rate of 1.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 154.98M | -89.99% |
| Dec 30, 2025 | 1.55B | -9.52% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 291.57M |
| Intervacc AB | 263.11M |
| Elicera Therapeutics AB | 177.19M |
| Simris Group AB (PUBL) | 163.32M |
| Abera Bioscience AB | 140.62M |
| Biovica International AB | 139.73M |
| Xintela AB | 134.36M |
| Initiator Pharma | 133.14M |